FDA Clearance Tracker · P040003
EXABLATE 2000 SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 22, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Oct 22, 2004
Approved
Time to decision
269 days
Received Jan 27, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P040003
- Device name
- EXABLATE 2000 SYSTEM
- Applicant
- Insightec, Ltd.
- Applicant location
- Dallas, TX
- Received
- Jan 27, 2004
- Decided
- Oct 22, 2004
- Decision
- Approved
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 20 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE EXABLATE 2000 SYSTEM. THE DEVICE IS INDICATED FOR ABLATION OF UTERINE FIBROID TISSUE IN PRE-OR PERI-MENOPAUSAL WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS WHO DESIRE A UTERINE SPARING PROCEDURE. PATIENTS MUST HAVE A UTERINE SIZE OF LESS THAN 24 WEEKS AND HAVE COMPLETED CHILD BEARING.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NRZ (Ablation system, high intensity focused ultrasound (HIFU), MR-guided).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Insightec, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231378 · Decided Oct 30, 2023 · 171 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.